Get the Stockscreener App
418.57
0.12%
-0.52
After Hours:
417.80
-0.77
-0.18%
Overview
News
Price History
Option Chain
Financials
Why MSFT Down?
Discussions
Forecast
Stock Split
Dividend History
Microsoft Corp stock is traded at $418.57, with a volume of 22.31M.
It is down -0.12% in the last 24 hours and down -3.31% over the past month.
Microsoft develops and licenses consumer and enterprise software. It is known for its Windows operating systems and Office productivity suite. The company is organized into three equally sized broad segments: productivity and business processes (legacy Microsoft Office, cloud-based Office 365, Exchange, SharePoint, Skype, LinkedIn, Dynamics), intelligence cloud (infrastructure- and platform-as-a-service offerings Azure, Windows Server OS, SQL Server), and more personal computing (Windows Client, Xbox, Bing search, display advertising, and Surface laptops, tablets, and desktops).
See More
Previous Close:
$419.09
Open:
$419.535
24h Volume:
22.31M
Relative Volume:
0.67
Market Cap:
$3.11T
Revenue:
$318.27B
Net Income/Loss:
$125.22B
P/E Ratio:
24.93
EPS:
16.79
Net Cash Flow:
$72.92B
1W Performance:
-0.79%
1M Performance:
-3.31%
6M Performance:
-11.34%
1Y Performance:
-7.98%
1-Day Range:
$416.33
$424.40
1-Week Range:
$411.30
$432.70
52-Week Range:
$356.28
$555.45
Microsoft Corp Stock (MSFT) Company Profile
Name
Microsoft Corp
Sector
Industry
Phone
425-882-8080
Address
ONE MICROSOFT WAY, REDMOND, WA
Compare MSFT vs ORCL, PLTR, CRWD, SNPS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MSFT
Microsoft Corp
|
418.57 | 3.11T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
192.08 | 545.79B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
136.88 | 329.43B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
663.46 | 165.00B | 4.81B | -181.85M | 1.24B | -0.7398 |
SNPS
Synopsys Inc
|
524.74 | 96.54B | 8.00B | 1.10B | 2.28B | 6.4708 |
Microsoft Corp Stock (MSFT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-30-26 | Reiterated | BMO Capital Markets | Outperform |
| Apr-30-26 | Reiterated | Barclays | Overweight |
| Apr-30-26 | Reiterated | Bernstein | Outperform |
| Apr-30-26 | Reiterated | Citigroup | Buy |
| Apr-30-26 | Reiterated | Deutsche Bank | Buy |
| Apr-30-26 | Reiterated | Evercore ISI | Outperform |
| Apr-30-26 | Reiterated | Piper Sandler | Overweight |
| Apr-30-26 | Reiterated | Stifel | Hold |
| Apr-30-26 | Reiterated | The Benchmark Company | Buy |
| Apr-30-26 | Reiterated | Truist | Buy |
| Apr-30-26 | Reiterated | Wells Fargo | Overweight |
| Apr-28-26 | Reiterated | BMO Capital Markets | Outperform |
| Apr-21-26 | Reiterated | Citigroup | Buy |
| Apr-15-26 | Reiterated | Robert W. Baird | Outperform |
| Apr-14-26 | Reiterated | Mizuho | Outperform |
| Apr-14-26 | Reiterated | Piper Sandler | Overweight |
| Mar-25-26 | Reiterated | UBS | Buy |
| Mar-24-26 | Resumed | BofA Securities | Buy |
| Feb-09-26 | Downgrade | Melius | Buy → Hold |
| Feb-05-26 | Downgrade | Stifel | Buy → Hold |
| Feb-03-26 | Resumed | Piper Sandler | Overweight |
| Jan-29-26 | Reiterated | BMO Capital Markets | Outperform |
| Jan-29-26 | Reiterated | Barclays | Overweight |
| Jan-29-26 | Reiterated | Bernstein | Outperform |
| Jan-29-26 | Reiterated | Citigroup | Buy |
| Jan-29-26 | Reiterated | Deutsche Bank | Buy |
| Jan-29-26 | Reiterated | Evercore ISI | Outperform |
| Jan-29-26 | Reiterated | Goldman | Buy |
| Jan-29-26 | Reiterated | JP Morgan | Overweight |
| Jan-29-26 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jan-29-26 | Reiterated | Piper Sandler | Overweight |
| Jan-29-26 | Reiterated | Robert W. Baird | Outperform |
| Jan-29-26 | Reiterated | Stifel | Buy |
| Jan-29-26 | Reiterated | Wedbush | Outperform |
| Jan-29-26 | Reiterated | Wells Fargo | Overweight |
| Jan-26-26 | Reiterated | Stifel | Buy |
| Jan-23-26 | Reiterated | UBS | Buy |
| Jan-21-26 | Reiterated | Citigroup | Buy |
| Jan-21-26 | Reiterated | Mizuho | Outperform |
| Jan-12-26 | Reiterated | Barclays | Overweight |
| Jan-12-26 | Resumed | Goldman | Buy |
| Jan-08-26 | Reiterated | Wells Fargo | Overweight |
| Nov-18-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Nov-14-25 | Initiated | Robert W. Baird | Outperform |
| Oct-30-25 | Reiterated | BMO Capital Markets | Outperform |
| Oct-27-25 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-22-25 | Reiterated | Citigroup | Buy |
| Oct-17-25 | Reiterated | Mizuho | Outperform |
| Oct-06-25 | Reiterated | Wells Fargo | Overweight |
| Jul-31-25 | Reiterated | BMO Capital Markets | Outperform |
| Jul-31-25 | Reiterated | Barclays | Overweight |
| Jul-31-25 | Reiterated | Bernstein | Outperform |
| Jul-31-25 | Reiterated | BofA Securities | Buy |
| Jul-31-25 | Reiterated | Jefferies | Buy |
| Jul-31-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-31-25 | Reiterated | Mizuho | Outperform |
| Jul-31-25 | Reiterated | Morgan Stanley | Overweight |
| Jul-31-25 | Reiterated | Oppenheimer | Outperform |
| Jul-31-25 | Reiterated | TD Cowen | Buy |
| Jul-31-25 | Reiterated | UBS | Buy |
| Jul-31-25 | Reiterated | Wedbush | Outperform |
| Jul-31-25 | Reiterated | Wells Fargo | Overweight |
| Jul-22-25 | Reiterated | Citigroup | Buy |
| Jul-16-25 | Reiterated | Cantor Fitzgerald | Overweight |
| Jul-16-25 | Reiterated | Mizuho | Outperform |
| Jul-09-25 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-02-25 | Reiterated | DA Davidson | Buy |
| Jun-25-25 | Reiterated | Wedbush | Outperform |
| Jun-11-25 | Reiterated | Citigroup | Buy |
| May-01-25 | Reiterated | BMO Capital Markets | Outperform |
| May-01-25 | Reiterated | Barclays | Overweight |
| May-01-25 | Reiterated | Evercore ISI | Outperform |
| May-01-25 | Reiterated | Goldman | Buy |
| May-01-25 | Reiterated | JP Morgan | Overweight |
| May-01-25 | Reiterated | Mizuho | Outperform |
| May-01-25 | Reiterated | Piper Sandler | Overweight |
| May-01-25 | Reiterated | RBC Capital Mkts | Outperform |
| May-01-25 | Reiterated | Raymond James | Outperform |
| May-01-25 | Reiterated | Scotiabank | Sector Outperform |
| May-01-25 | Reiterated | Stifel | Buy |
| May-01-25 | Reiterated | Wedbush | Outperform |
| Apr-17-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-16-25 | Reiterated | BMO Capital Markets | Outperform |
| Apr-16-25 | Reiterated | Morgan Stanley | Overweight |
| Apr-14-25 | Reiterated | UBS | Buy |
| Apr-14-25 | Reiterated | Wells Fargo | Overweight |
| Mar-20-25 | Initiated | Scotiabank | Sector Outperform |
| Mar-13-25 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-17-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-06-25 | Reiterated | Piper Sandler | Overweight |
| Oct-31-24 | Reiterated | BMO Capital Markets | Outperform |
| Oct-10-24 | Reiterated | Goldman | Buy |
| Oct-08-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-23-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jun-10-24 | Initiated | New Street | Buy |
| Jun-07-24 | Reiterated | Oppenheimer | Outperform |
| Apr-17-24 | Reiterated | Wells Fargo | Overweight |
| Apr-12-24 | Reiterated | BMO Capital Markets | Outperform |
| Apr-11-24 | Reiterated | Morgan Stanley | Overweight |
| Mar-21-24 | Initiated | KeyBanc Capital Markets | Overweight |
| Jan-18-24 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Dec-13-23 | Initiated | Truist | Buy |
| Dec-05-23 | Initiated | China Renaissance | Buy |
| Oct-26-23 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-17-23 | Initiated | Loop Capital | Buy |
| Sep-25-23 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-15-23 | Initiated | HSBC Securities | Hold |
| Jul-24-23 | Reiterated | Goldman | Buy |
| Jul-24-23 | Reiterated | Raymond James | Outperform |
| Jul-21-23 | Reiterated | Goldman | Buy |
| Jul-19-23 | Reiterated | Barclays | Overweight |
| Jul-19-23 | Reiterated | BofA Securities | Buy |
| Jul-19-23 | Reiterated | Mizuho | Buy |
| Jul-19-23 | Reiterated | TD Cowen | Outperform |
| Jul-19-23 | Reiterated | Wells Fargo | Overweight |
| Jul-17-23 | Reiterated | Mizuho | Buy |
| Jul-14-23 | Upgrade | UBS | Neutral → Buy |
| Jul-13-23 | Reiterated | Oppenheimer | Outperform |
| Apr-26-23 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Apr-26-23 | Reiterated | Goldman | Buy |
| Apr-26-23 | Reiterated | Guggenheim | Sell |
| Apr-26-23 | Reiterated | JP Morgan | Overweight |
| Apr-26-23 | Reiterated | Jefferies | Buy |
| Apr-26-23 | Upgrade | Macquarie | Neutral → Outperform |
| Apr-26-23 | Reiterated | Mizuho | Buy |
| Apr-26-23 | Reiterated | MoffettNathanson | Market Perform |
| Apr-26-23 | Reiterated | Morgan Stanley | Overweight |
| Apr-26-23 | Reiterated | Oppenheimer | Outperform |
| Apr-26-23 | Reiterated | Piper Sandler | Overweight |
| Apr-26-23 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-26-23 | Reiterated | Raymond James | Outperform |
| Apr-26-23 | Reiterated | Rosenblatt | Buy |
| Apr-26-23 | Reiterated | Stifel | Buy |
| Apr-26-23 | Reiterated | TD Cowen | Outperform |
| Apr-26-23 | Reiterated | UBS | Neutral |
| Apr-26-23 | Reiterated | Wedbush | Outperform |
| Apr-26-23 | Reiterated | Wells Fargo | Overweight |
| Apr-26-23 | Reiterated | Wolfe Research | Outperform |
| Apr-24-23 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Apr-21-23 | Reiterated | BMO Capital Markets | Market Perform |
| Apr-20-23 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-19-23 | Reiterated | BofA Securities | Buy |
| Apr-19-23 | Reiterated | Citigroup | Buy |
| Apr-19-23 | Reiterated | Deutsche Bank | Buy |
| Jan-25-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Jan-17-23 | Downgrade | Guggenheim | Neutral → Sell |
| Jan-05-23 | Initiated | DA Davidson | Buy |
| Jan-04-23 | Downgrade | UBS | Buy → Neutral |
| Nov-02-22 | Initiated | Macquarie | Neutral |
| Oct-14-22 | Reiterated | Morgan Stanley | Overweight |
| Sep-30-22 | Resumed | Raymond James | Outperform |
| Sep-22-22 | Initiated | MoffettNathanson | Hold |
| Aug-12-22 | Initiated | Guggenheim | Neutral |
| Jul-27-22 | Reiterated | BMO Capital Markets | Outperform |
| Jul-27-22 | Reiterated | Citigroup | Buy |
| Jul-27-22 | Reiterated | Cowen | Outperform |
| Jul-27-22 | Reiterated | Deutsche Bank | Buy |
| Jul-27-22 | Reiterated | Stifel | Buy |
| Jul-27-22 | Reiterated | Wedbush | Outperform |
| Jul-26-22 | Initiated | Itau BBA | Outperform |
| Jul-19-22 | Reiterated | Citigroup | Buy |
| Jun-29-22 | Initiated | Redburn | Buy |
| Apr-27-22 | Reiterated | BMO Capital Markets | Outperform |
| Apr-27-22 | Reiterated | Deutsche Bank | Buy |
| Apr-27-22 | Reiterated | Evercore ISI | In-line |
| Apr-27-22 | Reiterated | Stifel | Buy |
| Apr-27-22 | Reiterated | Wedbush | Outperform |
| Apr-27-22 | Reiterated | Wolfe Research | Outperform |
| Jan-26-22 | Reiterated | BMO Capital Markets | Outperform |
| Jan-26-22 | Reiterated | Citigroup | Buy |
| Jan-26-22 | Reiterated | Morgan Stanley | Overweight |
| Jan-26-22 | Reiterated | Oppenheimer | Outperform |
| Jan-12-22 | Reiterated | BMO Capital Markets | Outperform |
| Dec-22-21 | Initiated | SMBC Nikko | Outperform |
| Nov-22-21 | Initiated | Wells Fargo | Overweight |
| Nov-16-21 | Resumed | Credit Suisse | Outperform |
| Nov-02-21 | Initiated | Deutsche Bank | Buy |
| Oct-27-21 | Reiterated | Barclays | Overweight |
| Oct-27-21 | Reiterated | BofA Securities | Buy |
| Oct-27-21 | Reiterated | Cowen | Outperform |
| Oct-27-21 | Reiterated | Credit Suisse | Outperform |
| Oct-27-21 | Reiterated | Goldman | Buy |
| Oct-27-21 | Reiterated | Mizuho | Buy |
| Oct-27-21 | Reiterated | Morgan Stanley | Overweight |
| Oct-27-21 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-21 | Reiterated | Stifel | Buy |
| Sep-17-21 | Resumed | Rosenblatt | Buy |
| Sep-14-21 | Reiterated | Morgan Stanley | Overweight |
| Aug-20-21 | Reiterated | Mizuho | Buy |
| Jul-28-21 | Reiterated | Barclays | Overweight |
| Jul-28-21 | Reiterated | Bernstein | Outperform |
| Jul-28-21 | Reiterated | BofA Securities | Buy |
| Jul-28-21 | Reiterated | Citigroup | Buy |
| Jul-28-21 | Reiterated | Cowen | Outperform |
| Jul-28-21 | Reiterated | Credit Suisse | Outperform |
| Jul-28-21 | Reiterated | Griffin Securities | Buy |
| Jul-28-21 | Reiterated | Mizuho | Buy |
| Jul-28-21 | Reiterated | Morgan Stanley | Overweight |
| Jul-28-21 | Reiterated | Piper Sandler | Overweight |
| Jul-28-21 | Resumed | RBC Capital Mkts | Outperform |
| Jul-28-21 | Reiterated | Rosenblatt | Buy |
| Jul-28-21 | Reiterated | Stifel | Buy |
| Jul-28-21 | Reiterated | Wolfe Research | Outperform |
| Jul-22-21 | Reiterated | BofA Securities | Buy |
| Jul-22-21 | Reiterated | Citigroup | Buy |
| Jul-22-21 | Reiterated | Cowen | Outperform |
| Jul-22-21 | Reiterated | KeyBanc Capital Markets | Overweight |
| Jun-23-21 | Reiterated | Wedbush | Outperform |
| May-13-21 | Initiated | Rosenblatt | Buy |
| Apr-23-21 | Initiated | Wolfe Research | Outperform |
| Apr-12-21 | Reiterated | BMO Capital Markets | Outperform |
| Apr-05-21 | Resumed | Credit Suisse | Outperform |
| Mar-16-21 | Resumed | Credit Suisse | Outperform |
| Mar-03-21 | Resumed | Citigroup | Buy |
| Jan-26-21 | Resumed | Raymond James | Strong Buy |
| Jan-22-21 | Initiated | Goldman | Buy |
| Dec-21-20 | Upgrade | Citigroup | Neutral → Buy |
| Dec-16-20 | Resumed | BofA Securities | Buy |
| Nov-24-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Nov-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Oct-14-20 | Resumed | UBS | Buy |
| Jul-23-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-20-20 | Reiterated | Stifel | Buy |
| Jul-15-20 | Reiterated | BMO Capital Markets | Outperform |
| Jul-09-20 | Reiterated | Wedbush | Outperform |
| Jun-24-20 | Reiterated | Argus | Buy |
| Jun-02-20 | Reiterated | Wells Fargo | Overweight |
| May-27-20 | Initiated | Summit Insights | Buy |
| Apr-30-20 | Reiterated | Griffin Securities | Buy |
| Jan-30-20 | Reiterated | Oppenheimer | Outperform |
| Jan-30-20 | Reiterated | Piper Sandler | Overweight |
| Jan-30-20 | Reiterated | RBC Capital Mkts | Outperform |
| Jan-30-20 | Reiterated | Raymond James | Strong Buy |
| Jan-30-20 | Reiterated | Stifel | Buy |
| Jan-30-20 | Reiterated | Wedbush | Outperform |
| Jan-30-20 | Reiterated | Wells Fargo | Overweight |
View All
Microsoft Corp Stock (MSFT) Latest News
What is Microsoft? Everything You Need to Know About Its History, Azure, and Copilot AI - TradingKey
This "Magnificent Seven" Stock Is the Worst Performer of 2026. Is It Finally a Buy? - The Motley Fool
Microsoft (MSFT) Executive Sells Shares, Reducing Holdings - GuruFocus
The Microsoft Disaster: Why Dropping the OpenAI Leash Flips the Entire Script for MSFT Stock - Barchart.com
Microsoft Stock (MSFT) Opinions on AI-Driven Growth and Analyst Ratings - Quiver Quantitative
Quote of the Day by Bill Gates on creativity: ‘If you give people tools, and they use their natural abilities….’ - Mint
Microsoft To Pay $250M To End Activision Merger Suit - Law360
Microsoft vs. Apple Stock: The Numbers Reveal a Clear Winner Heading Into H2 2026 - Barchart.com
Activision shareholders reach US$250 million settlement over Microsoft buyout - BNN Bloomberg
Activision shareholders reach $250 million settlement over Microsoft buyout - Reuters
Microsoft Stock Looks Mispriced as Azure Growth Defies AI Slowdown Fears - Investing.com
Microsoft reports are exposing AI’s real cost problem: Using the tech is more expensive than paying human employees - Yahoo! Finance Canada
Microsoft to Pay $250 Million to End Activision Deal Case (2) - Bloomberg Law News
RBC Capital reiterates Microsoft stock Outperform rating at $640 By Investing.com - Investing.com South Africa
EY and Microsoft to invest US$1 billion into co-developing AI solutions - Technology Record
Microsoft (MSFT) Restructures Leadership to Enhance AI Innovatio - GuruFocus
Microsoft Shuts Down Appeal In UPC Web Browsing Case - Law360
Microsoft’s Consumer Chief Marketing Officer Yusuf Mehdi Announces His Departure - Thurrott.com
Is Microsoft or Meta Platforms the Greatest Value on the Market? - The Globe and Mail
Microsoft Opens a New Front in the Fight Over Data for AI Agents - The Information
Microsoft Eyes Anthropic Deal to Expand AI Chip Reach - GuruFocus
Inside Microsoft’s high-stakes push to win back its AI lead - Yahoo! Finance Canada
The big strategy themes behind Microsoft's executive overhaul - Business Insider Africa
Warren Street Wealth Advisors LLC Decreases Stock Holdings in Microsoft Corporation $MSFT - MarketBeat
Kawasaki teams up with Nvidia, Microsoft, and others to develop physical AI - Seeking Alpha
Microsoft’s consumer marketing chief to leave next year - The Verge
Microsoft Eyes Major AI Infrastructure Breakthrough With Anthropic Chip Supply Talks - Arise News
EY and Microsoft to invest over $1bn in enterprise AI transformation - International Accounting Bulletin
Anthropic in talks to use Microsoft's custom Maia AI chipsreport - Data Center Dynamics
Microsoft and EY partner on $1 billion AI initiative for clients - Investing.com
Microsoft is letting Office users remove an annoying Copilot button - The Tech Buzz
O’Melveny smooths Microsoft partner acquisition - ICLG
Microsoft lets Office users remove Copilot button - Let's Data Science
Microsoft Reshapes Leadership for AI Era - Let's Data Science
J.P. Marvel Investment Advisors LLC Sells 2,191 Shares of Microsoft Corporation $MSFT - MarketBeat
Munich Reinsurance Co Stock Corp in Munich Has $155.87 Million Stake in Microsoft Corporation $MSFT - MarketBeat
Microsoft accused of leaking Dutch civil servants' names to U.S. government - NL Times
Anthropic in talks to use Microsoft Maia 200 AI chips - qz.com
Microsoft turns to video-game researcher to fire up Xbox revival - thestar.com.my
Why this money manager is buying Microsoft, Meta and selling Disney - The Globe and Mail
Kawasaki Heavy Teaming With Up With Nvidia, Microsoft in AI -- Update - marketscreener.com
Agentic Biotech Platform Patterns - Trend Hunter
Microsoft Is Losing Its Way in the AI Race. Can Copilot Get It Back on Track? - Moomoo
Coronation Fund Managers Ltd. Has $44.89 Million Stake in Microsoft Corporation $MSFT - MarketBeat
Microsoft Corporation $MSFT Position Reduced by Generali Investments Management Co LLC - MarketBeat
Anthropic reportedly eyes Microsoft Maia chips to cut Nvidia reliance - digitimes
Kawasaki Heavy Teaming With Up With Nvidia, Microsoft in AI - marketscreener.com
MICROSOFT CORP : RBC reiterates its Buy rating - marketscreener.com
TCI Slashes Microsoft Stake Over AI Disruption Risk - HedgeCo.net
Office users hated the new Copilot button, now Microsoft is changing it - Neowin
Microsoft Stock: The Case For A Rerating Is Getting Stronger (NASDAQ:MSFT) - Seeking Alpha
Microsoft Corp Stock (MSFT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.22%
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):